Related Experiment Video
Updated: Oct 21, 2025

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
Published on: January 17, 2020
On computational classification of genetic cardiac diseases applying iPSC cardiomyocytes
Martti Juhola1, Henry Joutsijoki1, Kirsi Penttinen2
1Faculty of Information Technology and Communication Sciences, Tampere University, 33014 Finland.
Insights
Machine learning effectively classifies genetic cardiac diseases using calcium transient data from human induced pluripotent stem cells (iPSC-CMs). This approach accurately distinguishes between healthy controls and various genetic heart conditions.
Area of Science:
- Biomedical Engineering
- Cardiology
- Computational Biology
Background:
- Human induced pluripotent stem cells (iPSC-CMs) offer a model for studying genetic cardiac diseases.
- Abnormal calcium transients in cardiomyocytes are linked to impaired contractility and arrhythmias in genetic heart conditions.
- Existing research utilizes iPSC-CMs and machine learning for disease classification.
Purpose of the Study:
- To classify genetic cardiac diseases using calcium (Ca2+) transient data and machine learning algorithms.
- To extend previous findings by including data from two additional genetic heart diseases: dilated cardiomyopathy and Long QT Syndrome 2.
- To compare classification accuracies using leave-one-out versus 10-fold cross-validation methods.
Main Methods:
- Calcium transients were measured from disease-specific iPSC-CMs.
- Machine learning algorithms were applied to peak attributes of calcium transient signals.
- Classification was performed to differentiate between various genetic cardiac diseases and healthy controls.
Main Results:
- The study successfully extended disease classification to include dilated cardiomyopathy and Long QT Syndrome 2.
- Machine learning models achieved good classification accuracies despite increased complexity and number of diseases.
- Leave-one-out and 10-fold cross-validation yielded comparable classification results.
Conclusions:
- Accurate classification of multiple genetic cardiac diseases is achievable using iPSC-CM calcium transient data and machine learning.
- The study validates the utility of iPSC-CMs as a model for understanding disease mechanisms.
- Both leave-one-out and 10-fold cross-validation are reliable methods for assessing model performance in this context.
Background:
Cardiomyocytes differentiated from human induced pluripotent stem cells (iPSC-CMs) can be used to study genetic cardiac diseases. In patients these diseases are manifested e.g. with impaired contractility and fatal cardiac arrhythmias, and both of these can be due to abnormal calcium transients in cardiomyocytes. Here we classify different genetic cardiac diseases using Ca2+ transient data and different machine learning algorithms.
Methods:
By studying calcium cycling of disease-specific iPSC-CMs and by using calcium transients measured from these cells it is possible to classify diseases from each other and also from healthy controls by applying machine learning computation on the basis of peak attributes detected from calcium transient signals.
Results:
In the current research we extend our previous study having Ca-transient data from four different genetic diseases by adding data from two additional diseases (dilated cardiomyopathy and long QT Syndrome 2). We also study, in the light of the current data, possible differences and relations when machine learning modelling and classification accuracies were computed by using either leave-one-out test or 10-fold cross-validation.
Conclusions:
Despite more complex classification tasks compared to our earlier research and having more different genetic cardiac diseases in the analysis, it is still possible to attain good disease classification results. As excepted, leave-one-out test and 10-fold cross-validation achieved virtually equal results.
More Related Videos
Related Concept Videos
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
Cardiomyopathy I: Introduction and Classification

